Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cytyc Corporation Announces Pricing of $220 Million Convertible Notes Offering.


Business Editors/Health/Medical Writers

BOXBOROUGH, Mass.--(BUSINESS WIRE)--March 17, 2004

Cytyc Corporation (Nasdaq: CYTC) today announced that it has entered into an agreement, subject to customary closing conditions, for the sale of $220 million of 2.25% convertible notes due 2024. Cytyc has granted the initial purchasers a 13-day option to purchase up to an additional $30 million of notes. The offering is expected to close on March 22, 2004. Cytyc intends to use the net proceeds Net Proceeds

The amount received after all costs are deducted from the sale of a piece of property or security.

Notes:
In the case of an investor selling a security, net proceeds represent the proceeds from the sale minus any trading costs (i.e. commissions).
 of this offering towards the financing of its previously announced acquisition of Novacept, a California corporation. If the acquisition of Novacept is not consummated, Cytyc intends to use the net proceeds from this offering for general corporate purposes, general working capital and possible future acquisitions.

The notes will be convertible under certain circumstances into shares of Cytyc's common stock at an initial conversion rate of 33.7041 shares per $1,000 principal amount of notes. This represents a conversion price of $29.67 per common share, or a conversion premium of 50.00%.

The notes will bear interest at 2.25% per annum Per annum

Yearly.
 payable semiannually. Cytyc will also pay contingent interest contingent interest n. an interest in real property which, according to the deed (or a will or trust), a party will receive only if a certain event occurs or certain circumstances happen.  on the notes during any six month interest period beginning March 15, 2009, in which the trading price Trading price

The price at which a security is currently selling.
 of the notes for a specified period of time equals or exceeds 120% of the principal amount of the notes. Beginning March 20, 2009, Cytyc may redeem any of the notes at par plus accrued and unpaid interest. The holders of the notes may require Cytyc to redeem the notes on March 15 of 2009, 2014 and 2019, or on the occurrence of certain designated events affecting Cytyc, at par plus accrued and unpaid interest.

The notes and the common stock issuable upon conversion of the notes have not been registered under the Securities Act of 1933 or applicable state securities laws and, unless so registered, may not be offered or sold in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  except pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws.

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful.

Forward-Looking Statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 

Except for the historical information contained herein, the matters set forth in this press release, such as statements as to the expected use of net proceeds and the expected closing date of the offering, are forward-looking statements within the meaning of the "safe harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including market and other conditions or events that may affect Cytyc's ability to complete the offering or to use the net proceeds as intended, and other risks detailed from time to time in Cytyc's SEC reports, including its Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for the year ended December 31, 2003. Cytyc disclaims any intent or obligation to update these forward-looking statements.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Mar 17, 2004
Words:516
Previous Article:Bargain Network Motors Partners with Dealer Specialties to Ease the Used Car Buying Experience and Drive Qualified Consumers to Dealers.
Next Article:KPN and RIM to Offer BlackBerry In The Netherlands, Germany and Belgium.
Topics:



Related Articles
Cytyc Announces Extension of Exchange Offer.
Cytyc Announces Extension of Exchange Offer.
Cytyc Announces Extension of Exchange Offer.
Cytyc Corporation Announces Proposed Offering of $220 Million Convertible Senior Notes.
Cytyc Corporation Files Registration Statement for Resale of 2.25% Convertible Notes Due 2024.
Cytyc Announces Effectiveness of Registration Statement for Resale of 2.25% Convertible Notes Due 2024.
Cytyc Corporation Chairman and CEO Scheduled to Present at JP Morgan Healthcare Conference.
Cytyc Corporation Chairman and CEO Scheduled to Present at Piper Jaffray Health Care Conference.
Cytyc Announces Intention to Increase Tender Offer Price for Vision Systems Limited to A$3.25 Per Share; Intends to Declare Offer Unconditional.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles